Bath & Body Works, Inc. (NYSE:BBWI) Shares Acquired by Amalgamated Bank

Amalgamated Bank raised its position in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 45.4% in the first quarter, Holdings Channel.com reports. The fund owned 99,431 shares of the company’s stock after acquiring an additional 31,029 shares during the quarter. Amalgamated Bank’s holdings in Bath & Body Works were worth $3,015,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Bath & Body Works by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company’s stock valued at $1,093,306,000 after acquiring an additional 208,036 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in shares of Bath & Body Works by 4.3% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 10,235,086 shares of the company’s stock valued at $396,815,000 after purchasing an additional 422,973 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Bath & Body Works by 5.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,494,089 shares of the company’s stock valued at $329,317,000 after purchasing an additional 445,887 shares during the last quarter. Alliancebernstein L.P. increased its holdings in shares of Bath & Body Works by 35.6% in the fourth quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company’s stock valued at $200,768,000 after purchasing an additional 1,360,264 shares during the last quarter. Finally, Anomaly Capital Management LP increased its holdings in shares of Bath & Body Works by 38.3% in the fourth quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company’s stock valued at $188,456,000 after purchasing an additional 1,346,752 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. UBS Group increased their price target on Bath & Body Works from $32.00 to $36.00 and gave the company a “neutral” rating in a report on Tuesday, May 20th. Barclays cut their price target on Bath & Body Works from $35.00 to $30.00 and set an “equal weight” rating for the company in a report on Friday, May 30th. JPMorgan Chase & Co. increased their price target on Bath & Body Works from $41.00 to $43.00 and gave the company an “overweight” rating in a report on Monday, May 19th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the company an “overweight” rating in a report on Thursday, May 15th. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and issued a $38.00 price target (down previously from $43.00) on shares of Bath & Body Works in a report on Thursday, May 29th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Bath & Body Works presently has an average rating of “Moderate Buy” and an average price target of $42.00.

View Our Latest Research Report on Bath & Body Works

Bath & Body Works Stock Up 1.1%

BBWI stock opened at $33.14 on Friday. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The business has a fifty day moving average of $29.84 and a two-hundred day moving average of $32.74. The stock has a market cap of $7.01 billion, a price-to-earnings ratio of 8.84, a price-to-earnings-growth ratio of 1.11 and a beta of 1.72.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%. The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.42 billion. During the same period last year, the business posted $0.38 earnings per share. The company’s quarterly revenue was up 2.9% on a year-over-year basis. As a group, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 20th. Stockholders of record on Friday, June 6th were given a dividend of $0.20 per share. The ex-dividend date was Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 2.41%. Bath & Body Works’s dividend payout ratio is currently 21.33%.

About Bath & Body Works

(Free Report)

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Recommended Stories

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.